Abstract

High-throughput, “next-generation” sequencing methods are now being broadly applied across all fields of biomedical research, including respiratory disease, critical care, and sleep medicine. Although there are numerous review articles and best practice guidelines related to sequencing methods and data analysis, there are fewer resources summarizing issues related to study design and interpretation, especially as applied to common, complex, nonmalignant diseases. To address these gaps, a single-day workshop was held at the American Thoracic Society meeting in May 2017, led by the American Thoracic Society Section on Genetics and Genomics. The aim of this workshop was to review the design, analysis, interpretation, and functional follow-up of high-throughput sequencing studies in respiratory, critical care, and sleep medicine research. This workshop brought together experts in multiple fields, including genetic epidemiology, biobanking, bioinformatics, and research ethics, along with physician-scientists with expertise in a range of relevant diseases. The workshop focused on application of DNA and RNA sequencing research in common chronic diseases and did not cover sequencing studies in lung cancer, monogenic diseases (e.g., cystic fibrosis), or microbiome sequencing. Participants reviewed and discussed study design, data analysis and presentation, interpretation, functional follow-up, and reporting of results. This report summarizes the main conclusions of the workshop, specifically addressing the application of these methods in respiratory, critical care, and sleep medicine research. This workshop report may serve as a resource for our research community as well as for journal editors and reviewers of sequencing-based manuscript submissions in our research field.

Highlights

  • High-throughput, “next-generation” sequencing methods are being broadly applied across all fields of biomedical research, including respiratory disease, critical care, and sleep medicine

  • Reviews and bestpractices guidelines for DNA and RNA sequencing have been published [16, 17], this workshop focused on the application of DNA and RNA sequencing to common, complex diseases in human populations but not on epigenome or microbiome studies or cancer genetics

  • Study Designs and Phenotyping for Genetic Epidemiology The general principles of epidemiology study design remain true for genetic epidemiology studies, including subject ascertainment, phenotype definition, and sample size considerations, as summarized in the Strengthening the Reporting of Genetic Association Studies (STREGA) Guidelines [18]

Read more

Summary

Introduction

High-throughput, “next-generation” sequencing methods are being broadly applied across all fields of biomedical research, including respiratory disease, critical care, and sleep medicine. There are numerous review articles and best practice guidelines related to sequencing methods and data analysis, there are fewer resources summarizing issues related to study design and interpretation, especially as applied to common, complex, nonmalignant diseases To address these gaps, a single-day workshop was held at the American Thoracic Society meeting in May 2017, led by the American Thoracic Society Section on Genetics and Genomics. A single-day workshop was held at the American Thoracic Society meeting in May 2017, led by the American Thoracic Society Section on Genetics and Genomics The aim of this workshop was to review the design, analysis, interpretation, and functional follow-up of highthroughput sequencing studies in respiratory, critical care, and sleep medicine research.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call